Rational

After decades of research and clinical trials, vaccines are beginning to impact patient out- comes. While the future is bright, we still have a long way to go. This event will be an international meeting for experts to share and discuss the latest findings and future perspectives on cancer vaccines. The objectives of the conference are to:
There will be panel discussions embedded in each session to address questions raised by presentations, allow time to consider visions for the future, identify the hurdles that remain, and summarize areas of consensus and/or disagreement.

Presidency

Paolo A. Ascierto, Director of Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, National Cancer Institute IRCCS “Fondazione G. Pascale”, Naples, Italy

Bernard A. Fox, Chief of Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Institute, Portland, Oregon, US

Faculty

Nina Bhardwaj,
The Tisch Cancer Institute at Mount Sinai, New York, NY, US

William Freed-Pastor,
Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, US

Pablo Guasp,
Memorial Sloan Kettering Cancer Center, New York, NY, US

Rom Leidner,
Providence Cancer Institute: Earle A. Chiles Research Institute, Portland, OR, US

Kees Melief,
Leiden University Medical Center, Leiden, The Netherlands

Erwei Song,
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, Guangdong,China

Ryan Sullivan,
Harvard Medical School, Massachusetts General Hospital, Boston, MA, US

Inge Marie Svane,
Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Copenaghen, Denmark

Pierre Thibault,
Institute for Research in Immunology and Cancer, Montreal, Canada

Jonathan Yewdell,
National Institutes of Health, NIAID/DIR, Bethesda, MD, US

Lei Zheng,
Johns Hopkins School of Medicine, Baltimora, MD, US

Organizational Secretariat

Media Partnership

Informazioni

[regButton qlev="3"]

Download Program

Video Messages